Relievant Medsystems
Signal active
Organization
Contact Information
Overview
Relievant provides patients with low-risk therapy that affords the ability to alleviate their back pain. The company's Relievant’s Intracept System delivers targeted energy into the spine and blocks the transmission of pain signals from the basivertebral nerve.
About
Industries
Biotechnology, Health Care, Medical
Founded
2006
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Relievant Medsystems headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $29.5B in funding across 108 round(s). With a team of 11-50 employees, Relievant Medsystems is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Relievant Medsystems, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
4
Lead Investors
0
Total Funding Amount
$273.6M
Details
7
Relievant Medsystems has raised a total of $273.6M in funding over 7 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2016 | Late Stage Venture | 36.0M | ||
| 2006 | Early Stage Venture | 5.0M | ||
| 2012 | Late Stage Venture | 30.0M | ||
| 2009 | Late Stage Venture | 20.0M |
Investors
Relievant Medsystems is funded by 38 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Jason Lettmann | - | FUNDING ROUND - Jason Lettmann | 36.0M |
| Morgenthaler Ventures | - | FUNDING ROUND - Morgenthaler Ventures | 36.0M |
| Relievant Medsystems | - | FUNDING ROUND - Relievant Medsystems | 36.0M |
| Emergent Medical Partners | - | FUNDING ROUND - Emergent Medical Partners | 36.0M |
Recent Activity
There is no recent news or activity for this profile.